Formulation for the treatment and/or prophylaxis of dementia

Details Formulation for the treatment and/or prophylaxis of dementia Formulation for the treatment and/or prophylaxis of dementia

A - Human Necessities

61

K

A61K 31/435 (2006.01) A61K 9/70 (2006.01) A61K 31/439 (2006.01)

Patent

CA 2261233

A pharmaceutical composition for administration to the skin, which comprises [R-(Z)]-.alpha.-(methoxyimino)-.alpha.-(1-azabicyclo [2.2.2]oct-3- yl)acetonitrile or a pharmaceutically acceptable salt thereof together with a suitable pharmaceutically acceptable carrier, for the treatment or prophylaxis of dementia.

Une composition pharmaceutique destinée à être administrée par voie transdermique, qui comprend le composé [R-(Z)]-.alpha.-(méthoxyimino)-.alpha.-(1-azabicyclo [2.2.2]oct-3-yl)acétonitrile ou un sel pharmaceutiquement acceptable dudit composé, associé à un support pharmaceutiquement acceptable approprié, est utile pour le traitement et la prophylaxie de la démence.

Affiliated with

Also associated with

Rating

Formulation for the treatment and/or prophylaxis of dementia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Formulation for the treatment and/or prophylaxis of dementia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formulation for the treatment and/or prophylaxis of dementia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1710714